<DOC>
	<DOC>NCT00536393</DOC>
	<brief_summary>Interest of the use of pegylated liposomal doxorubicin (ca√©lyx)</brief_summary>
	<brief_title>Treatment of Disseminated High Grade Lymphoma</brief_title>
	<detailed_description>R CHOP is a good standard in the treatment of diffuse high grade lymphoma. Howeverin elderly patients it is often toxic, specially with haematologic and cardiac toxicities.</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma, Non-Hodgkin</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<criteria>high grade lymphoma disseminated &gt; 60 years old and &lt; 75 informed consent signed cardiac state compatible with antracyclin ECOG &lt;/= 2 patients &gt; 75 years old Cardiac insufficiency</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2007</verification_date>
	<keyword>diffuse larg cells lymphoma</keyword>
	<keyword>chemotherapy</keyword>
	<keyword>toxicity</keyword>
	<keyword>diffuse high grade lymphoma</keyword>
</DOC>